NK cells prevalence, subsets and function in viral hepatitis C. (Q37942504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

review article

1 reference

title

NK cells prevalence, subsets and function in viral hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

Iwona Mozer-Lisewska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Arleta Kowala-Piaskowska

series ordinal

4

object named as

Arleta Kowala-Piaskowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

Jan Zeromski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Jan Sikora

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

5 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

Archivum Immunologiae et Therapiae Experimentalis

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

449-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Activation of natural killer cells during acute infection with hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Natural killer cells and hepatitis C: action and reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Innate and adaptive lymphoid cells in the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Peptide antagonism as a mechanism for NK cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

The global burden of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Amelioration of hepatic fibrosis by NK cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Adaptive immune responses mediated by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Natural killer cells suppress full cycle HCV infection of human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

CD56 negative NK cells: origin, function, and role in chronic viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0145-Y

10.1007/S00005-011-0145-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21972016%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference